Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Repeat expansions in Parkinson's disease and parkinsonism across ancestries: insights from a global genetic cohort.

medRxiv : the preprint server for health sciences·2026

Same author

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Same author

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes.

Nature cancer·2026

Same author

Pathology and Genetics in a Global Cohort of Parkinsonian Disorders.

JAMA neurology·2026

Same author

Fast segmentation with the NextBrain histological atlas.

Imaging neuroscience (Cambridge, Mass.)·2026

Same author

Diagnostic, Prognostic Value, and Pathological Associations of Levodopa Responsiveness in Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy.

Annals of neurology·2026

Same journal

Mutation-specific neuropathologic signatures in MAPT-associated frontotemporal lobar degeneration.

Acta neuropathologica·2026

Same journal

Molecular changes during AT/RT progression associated with epithelial-mesenchymal transition and extracellular matrix changes.

Acta neuropathologica·2026

Same journal

Prion-like transmission and propagation of human β-amyloid to the bank vole rodent model.

Acta neuropathologica·2026

Same journal

Inhibition of tRNA fragments dysregulated in human mTLE exacerbates pathology and seizure activity.

Acta neuropathologica·2026

Same journal

VMA21 deficiency leads to autophagic dysregulation and altered vesicle trafficking in X-linked myopathy with excessive autophagy.

Acta neuropathologica·2026

Same journal

Donor-specific pathological features associate with genetic background, lesion type distribution, and clinical heterogeneity in multiple sclerosis.

Acta neuropathologica·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 8, 2026

Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay

Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay

Published on: March 10, 2015

Prion disease: experimental models and reality.

Sebastian Brandner¹, Zane Jaunmuktane²

¹Department of Neurodegenerative Disease, UCL Institute of Neurology and Division of Neuropathology, The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Queen Square, London, WC1N 3BG, UK. s.brandner@ucl.ac.uk.

Acta Neuropathologica

|January 14, 2017

Summary

This summary is machine-generated.

Understanding prion disease pathogenesis requires diverse models, acknowledging their strengths and limitations. This review explores historical and technological advancements in prion disease modeling for research.

More Related Videos

Protein Misfolding Cyclic Amplification of Prions

Protein Misfolding Cyclic Amplification of Prions

Published on: November 7, 2012

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

Related Experiment Videos

Last Updated: Mar 8, 2026

Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay

Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay

Published on: March 10, 2015

Protein Misfolding Cyclic Amplification of Prions

Protein Misfolding Cyclic Amplification of Prions

Published on: November 7, 2012

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

Area of Science:

Neuroscience
Pathology
Biochemistry

Background:

Disease pathogenesis understanding necessitates a multidisciplinary approach combining clinical, pathological, and modeling strategies.
Developing comprehensive disease models that fully replicate human conditions remains a significant challenge.
Awareness of model system potentials and limitations is crucial for accurate scientific interpretation.

Purpose of the Study:

To evaluate and discuss various model systems employed in prion disease research.
To provide a historical overview of prion disease modeling evolution.
To examine how technological advancements have enhanced the understanding of prion biology.

Main Methods:

Review and analysis of existing literature on prion disease model systems.
Discussion of in vitro and in vivo studies contributing to understanding prion disease mechanisms.
Historical perspective on the development and application of prion disease models.

Main Results:

Model systems are indispensable for dissecting specific aspects of prion diseases, including transmission, replication, and toxicity.
Prion disease pathogenesis, similar to other protein misfolding neurodegenerative diseases, is intricate and presents complexities.
Advancements in technology have progressively refined our comprehension of prion biology through various modeling approaches.

Conclusions:

Model systems, despite inherent limitations, are vital for advancing prion disease research.
The evolution of modeling techniques reflects scientific progress in understanding prion diseases.
Continued development and critical evaluation of models are essential for future discoveries in prion biology.